POLYPEPTIDE LABORATORIES A/S: Financial statements 2025
CVR: 19056201
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
POLYPEPTIDE LABORATORIES A/S (CVR 19056201) has filed annual accounts for 2025. In 2025, the company reported a net result of DKK 2,632,000 compared with DKK 7,060,000 the year before. Equity in the 2025 report amounted to DKK 75,499,000. The solvency ratio was 100%.
- Profit/Loss
- DKK 2,632,000
- Equity
- DKK 75,499,000
- Total Assets
- DKK 75,519,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | - | 2.6 mio. | 75.5 mio. | 0 |
| 2024 | - | - | 7.1 mio. | 72.9 mio. | - |
| 2023 | - | - | 3.2 mio. | 65.8 mio. | - |
| 2022 | - | - | -3 mio. | 62.6 mio. | - |
| 2021 | - | - | -839 t. | 65.6 mio. | - |
Official annual report
How creditworthy is POLYPEPTIDE LABORATORIES A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of October 13, 2025, Juan José Gonzalez Casanova has joined the board of directors of POLYPEPTIDE LABORATORIES A/S.
As of October 13, 2025, Marc Friedrich Augustin has joined the board of directors of POLYPEPTIDE LABORATORIES A/S.
As of October 13, 2025, Jens Fricke has left the board of directors of POLYPEPTIDE LABORATORIES A/S.
As of October 13, 2025, Marc Friedrich Augustin is registered as director of POLYPEPTIDE LABORATORIES A/S.
As of October 13, 2025, Juan José Gonzalez Casanova has stepped down as director of POLYPEPTIDE LABORATORIES A/S.
As of October 12, 2025, Juan José Gonzalez Casanova has left the board of directors of POLYPEPTIDE LABORATORIES A/S.
POLYPEPTIDE LABORATORIES A/S has published its annual report for 2024. The net result was DKK 7,060,000.
About POLYPEPTIDE LABORATORIES A/S
POLYPEPTIDE LABORATORIES A/S is a Danish company of the type Aktieselskab based in Hillerød, founded in 1996. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named A/S PSE NR. 4948. The management consists of Raoul Bernhardt. The board consists of Juan José Gonzalez Casanova (chair), Christina Ellen Del Vecchio and Raoul Bernhardt. The company is owned by PolyPeptide Laboratories Holding (PPL) AB. The company has 0 employees (2017). In 2025, the company reported a net result of DKK 2,632,000 compared with DKK 7,060,000 the year before. Equity in the 2025 report amounted to DKK 75,499,000.